Luke Engelking, M.D., Ph.D.

Luke Engelking, M.D., Ph.D.

  • Internal Medicine - Digestive & Liver Diseases


Dr. Engelking is originally from Houston, Texas and first came to UT Southwestern for joint MD/PhD training (2000-2007), where he studied cholesterol and fat metabolism under the tutelage of Nobel Laureates Goldstein and Brown. He then completed his clinical training in internal medicine at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School.  Drawn by the opportunity to study lipid metabolism in the intestine, he returned to UT Southwestern for a fellowship in gastroenterology and hepatology (2010-2014) and thereafter joined the faculty of the Departments of Internal Medicine (Division of Digestive and Liver Diseases) and Molecular Genetics. His current research interests include understanding the role of the intestine in the control of metabolism, particularly focused on the intestine’s contribution to lipid-related disorders such as obesity, fatty liver disease, and hyperlipidemia.

See More

Education & Training
  • Fellowship - UT Southwestern Medical Center (2010-2014), Gastroenterology
  • Residency - Massachusetts General Hospital (2007-2010), Internal Medicine
  • Medical School - UT Southwestern Medical School (2000-2007)
Professional Associations & Affiliations
  • American Gastroenterological Association (2010), Member
  • American College of Gastroenterology (2014), Member
Honors & Awards
  • University Honors 2000, Texas A&M University
  • Alpha Omega Alpha 2007, Honor Medical Society
  • Distinguished Researcher's Award 2014, UT Southwestern President's Research Council
Books & Publications
  • SREBP, Scap and Insig Proteins
  • Enteroendocrine Cell Biology
  • Cholesterol and Fat Metabolism